Emerging literature indicates an increasing trend in chondrosarcoma rates, establishing it as the most common primary bone malignancy in certain countries, primarily due to incidental diagnoses of chondrosarcoma-associated lesions [ 3 , 4 ].
← all excerpts
C-Reactive Protein Pretreatment-Level Evaluation with Histopathological Correlation for Chondrosarcoma Prognosis Assessment-A 15-Year Retrospective Single-Center Study.
1
—
—